Address correspondence to Dr Kelly Gwathmey, Department of Neurology, Virginia Commonwealth University, 1101 East Marshall St, PO Box 980599, Richmond, VA 23298, [email protected].
RELATIONSHIP DISCLOSURE: Dr Gwathmey has served as a consultant for and received personal compensation for speaking engagements from Alexion Pharmaceuticals, Inc.
UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Dr Gwathmey discusses the unlabeled/investigational use of azathioprine, bortezomib, corticosteroids (methylprednisolone, prednisone), cyclophosphamide, cyclosporine, methotrexate, mycophenolate mofetil, and rituximab for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy and its variants.